 |
|
Antisoma buys into the US
A London-headquartered biotechnology company focused on the development of cancer drugs will enlarge its offering with the agreed acquisition of a US oncology company.
The all-share purchase of Massachusetts-based Xanthus Pharmaceuticals by Antisoma plc is valued at £26.8 million ($52.2 million) and represents the issue of a 22 per cent stake. The transaction is expected close at the beginning of June.
Antisoma’s pipeline will grow by three assets, resulting from the addition of Zanthus’ operations, including phase III oncology drug Xanafide and US rights to oral fludarabine, a niche oncology product in registration with the FDA.
Simultaneously, Antisoma has raised £20.9 million of funds, giving the enlarged business a strong balance sheet with starting cash of around £67 million.
Antisoma CEO Glyn Edwards says the “transforming” deal will produce a company with the critical mass and mature pipeline needed to become a major player in oncology.
Richard Dean, Xanthus CEO, adds: “We’re delighted to be joining forces with one of the emerging stars in oncology to produce a company with an impressive portfolio of drug candidates and the resources to maximise their value.”
People also read ... |
Related Articles |
Interesting links
Other Sector Watch
- Talking rubbish Jul 28 2008
- Crisis?– what crisis? Jul 01 2008
- Let the
drilling begin
May 13 2008 - Bargains on the high street
Mar 13 2008 - Sowing the seed Mar 03 2008
M&A News
- Impress Digital merges with local rival Aug 29 2008
- Mixed private equity signals Aug 29 2008
- Qatar National Bank deal shows consolidation trend Aug 28 2008
- Provident on the lookout for friends Aug 28 2008
- Blooming acquisition for United Online Aug 27 2008
Special Offers
- 2008 AIM Guide: Jul 17 2007
- Growth Company Investor Magazine: Jul 17 2007
- Cash Shells 2007 - Research report Jul 17 2007
- Venture Capital Trusts Jul 04 2007
M&A Deals
- Funding boost for Durham Pipeline Technology Aug 28 2008
- Hill & Smith’s US window of opportunity Aug 26 2008
- Glanbia muscles in on US deal Aug 26 2008
- Right prescription for Oxford John Radcliffe
Aug 22 2008 - Lights, camera, action for Litepanels deal Aug 22 2008
Business Diary
- Rosenblatt New Energy Awards 2009 27th February
- Enterprise Security 2008 25th September
- European Semantic Technology Conference 2008 24th September
- Business XL How to float on AIM 11th September
- Investor AllStars Venture Capital Awards 2008 16th September